Basic information
Biomarker: CYP1A1
Biomarker subtype: mRNA
Clinical application: treatment(chemotherapeutic targets)
Histology type: endometrial carcinoma
Cohort characteristics
Country: Greece
Region: Athens
Cohort age: 63.7;46–72
Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
---|---|---|---|---|---|---|---|---|
14 | EC | 14 |
Sample information
Sample type : tissue
Clinical method: qRT-PCR/Western blotting,enzyme activity assays,HPLC and mass spectrometry analysis
Expression pattern : overexpression
Disease information
Statictics: Mean ;Range
Cohort age: 63.7;46–72
Related information
Description: Overexpression of active CYP1 enzymes in 21 % of the tumors highlights the potential use of the latter enzymes as chemotherapeutic targets in endometrial cancer.
Approved symbol: CYP1A1
Approved name: cytochrome P450 family 1 subfamily A member 1
Locus type: gene with protein product
HGNC ID: HGNC:2595
HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:2595
Symbol status: Approved
Previous symbols: CYP1
Alias symbols: cytochrome P450, subfamily I (aromatic compound-inducible), polypeptide 1 cytochrome P450, family 1, subfamily A, polypeptide 1
Subgroup: Cytochrome P450s (CYP)
OMIM: 108330
Omim link: https://www.omim.org/entry/108330
NCBI name: 1543
NCBI link: https://www.ncbi.nlm.nih.gov/gene/1543
Summary: This gene, CYP1A1, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by some polycyclic aromatic hydrocarbons (PAHs), some of which are found in cigarette smoke. The enzyme's endogenous substrate is unknown; however, it is able to metabolize some PAHs to carcinogenic intermediates. The gene has been associated with lung cancer risk. A related family member, CYP1A2, is located approximately 25 kb away from CYP1A1 on chromosome 15. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jan 2016]
Expression: Biased expression in urinary bladder (RPKM 40.8), liver (RPKM 18.0) and 1 other tissue
NCBI gene expression https://www.ncbi.nlm.nih.gov/gene/1543#gene-expression
PDB ID: P04798
PDB link: https://www.ebi.ac.uk/pdbe/entry/search/index/?searchParams=%7B%22q_uniprot%22:%5B%7B%22value%22:%22(P04798)%22,%22condition1%22:%22AND%22,%22condition2%22:%22Contains%22%7D%5D,%22resultState%22:%7B%22tabIndex%22:0,%22paginationIndex%22:1,%22perPage%22:%2210%22,%22sortBy%22:%22Sort%20by%22%7D%7D
MF term ID: GO:0016711
MF term name: flavonoid 3'-monooxygenase activity
BP term ID: GO:0019341 | GO:0009692 | GO:0017143
BP term name: dibenzo-p-dioxin catabolic process| ethylene metabolic process | insecticide metabolic process
Source description: REAC
Term ID: REAC:R-HSA-9018681
Term name: Biosynthesis of protectins